These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25557624)

  • 1. Genotypic and phenotypic characteristics of aminoglycoside-resistant Mycobacterium tuberculosis isolates in Latvia.
    Bauskenieks M; Pole I; Skenders G; Jansone I; Broka L; Nodieva A; Ozere I; Kalvisa A; Ranka R; Baumanis V
    Diagn Microbiol Infect Dis; 2015 Mar; 81(3):177-82. PubMed ID: 25557624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.
    Du Q; Dai G; Long Q; Yu X; Dong L; Huang H; Xie J
    Diagn Microbiol Infect Dis; 2013 Oct; 77(2):138-42. PubMed ID: 23948547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis isolates in Sichuan, China and the association between Beijing-lineage and dual-mutation in gidB.
    Sun H; Zhang C; Xiang L; Pi R; Guo Z; Zheng C; Li S; Zhao Y; Tang K; Luo M; Rastogi N; Li Y; Sun Q
    Tuberculosis (Edinb); 2016 Jan; 96():102-6. PubMed ID: 26786661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.
    Jnawali HN; Yoo H; Ryoo S; Lee KJ; Kim BJ; Koh WJ; Kim CK; Kim HJ; Park YK
    World J Microbiol Biotechnol; 2013 Jun; 29(6):975-82. PubMed ID: 23329063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GidB mutation as a phylogenetic marker for Q1 cluster Mycobacterium tuberculosis isolates and intermediate-level streptomycin resistance determinant in Lisbon, Portugal.
    Perdigão J; Macedo R; Machado D; Silva C; Jordão L; Couto I; Viveiros M; Portugal I
    Clin Microbiol Infect; 2014 May; 20(5):O278-84. PubMed ID: 24102832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
    Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
    Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
    Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes.
    Nhu NT; Lan NT; Phuong NT; Chau Nv; Farrar J; Caws M
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):527-31. PubMed ID: 22640514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
    Engström A; Perskvist N; Werngren J; Hoffner SE; Juréen P
    J Antimicrob Chemother; 2011 Jun; 66(6):1247-54. PubMed ID: 21427106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.
    Zhang Z; Liu M; Wang Y; Pang Y; Kam KM; Zhao Y
    Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):1959-66. PubMed ID: 24906439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testing.
    Chakravorty S; Lee JS; Cho EJ; Roh SS; Smith LE; Lee J; Kim CT; Via LE; Cho SN; Barry CE; Alland D
    J Clin Microbiol; 2015 Jan; 53(1):43-51. PubMed ID: 25339395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and Genotypic Characterization of Streptomycin-Resistant Multidrug-Resistant
    Islam MM; Tan Y; Hameed HMA; Chhotaray C; Liu Z; Liu Y; Lu Z; Wang S; Cai X; Gao Y; Cai X; Guo L; Li X; Tan S; Yew WW; Zhong N; Liu J; Zhang T
    Microb Drug Resist; 2020 Jul; 26(7):766-775. PubMed ID: 31976809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.
    Sugawara I; Zhang J; Li C
    Indian J Exp Biol; 2009 Jun; 47(6):520-2. PubMed ID: 19634718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in rrs, rpsL and gidB in streptomycin-resistant Mycobacterium tuberculosis isolates from Thailand.
    Smittipat N; Juthayothin T; Billamas P; Jaitrong S; Rukseree K; Dokladda K; Chaiyasirinroje B; Disratthakit A; Chaiprasert A; Mahasirimongkol S; Yanai H; Yamada N; Tokunaga K; Palittapongarnpim P
    J Glob Antimicrob Resist; 2016 Mar; 4():5-10. PubMed ID: 27436385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis.
    Sirgel FA; Tait M; Warren RM; Streicher EM; Böttger EC; van Helden PD; Gey van Pittius NC; Coetzee G; Hoosain EY; Chabula-Nxiweni M; Hayes C; Victor TC; Trollip A
    Microb Drug Resist; 2012 Apr; 18(2):193-7. PubMed ID: 21732736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the MeltPro TB/STR assay for rapid detection of streptomycin resistance in Mycobacterium tuberculosis.
    Zhang T; Hu S; Li G; Li H; Liu X; Niu J; Wang F; Wen H; Xu Y; Li Q
    Tuberculosis (Edinb); 2015 Mar; 95(2):162-9. PubMed ID: 25553930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of GenoType MTBDRsl for testing resistance of Mycobacterium tuberculosis isolates to fluoroquinlone, aminoglycoside, and ethambutol].
    Chikamatsu K; Aono A; Yamada H; Mitarai S
    Kekkaku; 2012 Oct; 87(10):641-7. PubMed ID: 23214120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of rrs and rpsL mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from Iranian patients.
    Khosravi AD; Etemad N; Hashemzadeh M; Khandan Dezfuli S; Goodarzi H
    J Glob Antimicrob Resist; 2017 Jun; 9():51-56. PubMed ID: 28404234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and genotypic characteristics of drug resistance in Mycobacterium tuberculosis isolates from pediatric population of Chennai, India.
    Therese KL; Gayathri R; Balasubramanian S; Natrajan S; Madhavan HN
    Indian J Med Microbiol; 2012; 30(4):411-7. PubMed ID: 23183465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of rpsL and rrs mutations in Beijing and non-Beijing streptomycin-resistant Mycobacterium tuberculosis isolates from Singapore.
    Sun YJ; Luo JT; Wong SY; Lee AS
    Clin Microbiol Infect; 2010 Mar; 16(3):287-9. PubMed ID: 19519851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.